Elon Musk on Tuesday announced that his company Neuralink has implanted the first brain chip in a human patient. The initial results are "promising", the billionaire said, adding that the product is named after the ability to communicate mentally or Telepathy.
The first human received an implant from @Neuralink yesterday and is recovering well.
— Elon Musk (@elonmusk) January 29, 2024
Initial results show promising neuron spike detection.
"Initial results show promising neuron spike detection," Musk said in a post on X, referring to the brain's ability to send signals to the body.
The startup, which received clearance from the US health watchdog to conduct the first human trial of its implant last year, aims to use it to help paralysis patients.
How does it work?
In a post on X, Musk explained how the implant connects the brain to any electronic device, adding that the implant can be useful for the physically disabled.\
The first @Neuralink product is called Telepathy
— Elon Musk (@elonmusk) January 29, 2024
"Enables control of your phone or computer, and through them almost any device, just by thinking. Initial users will be those who have lost the use of their limbs. Imagine if Stephen Hawking could communicate faster than a speed typist or auctioneer. That is the goal," he said.
The implants, made of "ultra-fine" threads, can transmit signals from the brain and connect those to commands on an electronic device, Neuralink said.
How will it be used?
According to their website, the company's mission is to create a "generalized brain interface to restore autonomy to those with unmet medical needs."
The investigative trial called PRIME (Precise Robotically Implanted Brain-Computer Interface) will include quadriplegic patients as well as those who suffer from spinal cord injuries and even amyotrophic lateral sclerosis (ALS).
Check out our latest video to learn more about our PRIME Study! 🧠📱 pic.twitter.com/7zTMFzdZsF
— Neuralink (@neuralink) November 22, 2023
Is it safe?
Musk's ambitious endeavor to make telepathy a reality has also earned scrutiny as the company was fined this month for violating trial safety protocols.
Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.
